Hypoxia inducible factor-1 mediates the expression of the immune checkpoint HLA-G in glioma cells through hypoxia response element located in exon 2

HLA-G is an immune checkpoint molecule with specific relevance in cancer immunotherapy. It was first identified in cytotrophoblasts, protecting the fetus from maternal rejection. HLA-G tissue expression is very restricted but induced in numerous malignant tumors such as glioblastoma, contributing to...

Descripción completa

Detalles Bibliográficos
Autores principales: Yaghi, Layale, Poras, Isabelle, Simoes, Renata T., Donadi, Eduardo A., Tost, Jörg, Daunay, Antoine, de Almeida, Bibiana Sgorla, Carosella, Edgardo D., Moreau, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5325396/
https://www.ncbi.nlm.nih.gov/pubmed/27577073
http://dx.doi.org/10.18632/oncotarget.11628

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5325396/
https://www.ncbi.nlm.nih.gov/pubmed/27577073
http://dx.doi.org/10.18632/oncotarget.11628

Ejemplares similares